Christopher Gleason Appointed President and CEO of Moximed
Key Highlights Christopher Gleason appointed as President and CEO of Moximed MISHA® Knee System to expand access for…
Browsing Tag
Boston Scientific Corporation
3 posts
Nectero Medical Secures $96M in Series D for Aneurysm Trials
Key Highlights $96 million raised in Series D funding to boost Nectero Medical’s Phase II/III trials and FDA submission.…
AVS Appoints New VP of Clinical Affairs to Propel PIVL™ Therapy
Key Highlights Elizabeth Galle joins AVS with over two decades of experience in the medical device sector, notably as…